Viktor Kharitonin created multinational pharmaceutical firm Pharmstandard with Russian billionaire Roman Abramovich and other partners in 2003 by combining five factories.

Kharitonin and partner Egor Kulkov bought out the other investors in 2008, a year after Pharmstandard went public in London. They took Pharmstandard private again, eight years later.

Kharitonin and Kulkov also hold stakes in other Russian pharmaceuticals companies: OTCPharm, Biocad and Generium, one of the producers of the COVID-19 vaccine Sputnik V.

In 2022 The two partners tried to buy Russian assets of Austrian-British packaging and paper group Mondi for 1.5 billion euro, but Russian authorities rejected the deal.

In 2023 Kharitonin and his partners bought Russian assets of German chemical producer Henkel for 600 million euros, leaving Henkel the option of buying back the business.

Financial Assets

Financial assets information not available.

The Great Lie of Mega-Fortunes: The Case of Viktor Kharitonin

Billionaires are often presented under the romantic myth of the 'self-made person': a narrative designed to justify opulence as the natural reward for hard work, effort, or ingenuity. However, when confronting such extreme volumes of wealth with macroeconomic reality, the meritocracy narrative completely breaks down. No individual can legitimately generate through personal effort a fortune equivalent to millions of times the average working-class salary. Capital at the top does not grow because of exceptional talent; it expands through an implacable dynamic where accumulated money works exponentially faster than people, devouring the wealth generated by productive labor.

The immense fortune of Viktor Kharitonin, linked to Healthcare and 'Pharmaceuticals', has not been built in a free-market vacuum, but through rent-seeking, the use of exclusive elite influence, the consolidation of monopoly positions, or inherited wealth. Far from taking real private risks, billionaire empires structurally depend on state support through direct subsidies, infrastructure use, exploitation of R&D, public contracts, and offshore tax engineering. While this wealth is equivalent to the physical weight of 56 tons of pure gold, the rest of the planet suffers from an artificial scarcity of basic resources. The fact that this wealth is enough to fully fund the public health system of DR Congo, a country with more than 105800000 million inhabitants for 3.5 years, proves that unlimited accumulation is not an entrepreneurial achievement, but the hijacking of democratic sovereignty.

📖 Read our manifesto and discover the real problem of unlimited wealth